FGF Regulates TGF-β Signaling and Endothelial-to-Mesenchymal Transition via Control of let-7 miRNA Expression

Pei‐Yu Chen(Yale University), Lingfeng Qin(Yale University), Carmen Barnes(Alnylam Pharmaceuticals (United States)), Klaus Charissé(Alnylam Pharmaceuticals (United States)), Tai Yi(Yale University), Xinbo Zhang(Yale University), Rahmat Ali(Yale University), Pedro P. Medina(Yale University), Jun Yu(Yale University), Frank J. Slack(Yale University), Daniel G. Anderson(Harvard–MIT Division of Health Sciences and Technology), Victor Kotelianski(Massachusetts Institute of Technology), Fen Wang(Texas A&M Health Science Center), George Tellides(Yale University), Michael Simons(Yale University)
Cell Reports
November 29, 2012
Cited by 298Open Access
Full Text

Abstract

Maintenance of normal endothelial function is critical to various aspects of blood vessel function, but its regulation is poorly understood. In this study, we show that disruption of baseline fibroblast growth factor (FGF) signaling to the endothelium leads to a dramatic reduction in let-7 miRNA levels that, in turn, increases expression of transforming growth factor (TGF)-β ligands and receptors and activation of TGF-β signaling, leading to endothelial-to-mesenchymal transition (Endo-MT). We also find that Endo-MT is an important driver of neointima formation in a murine transplant arteriopathy model and in rejection of human transplant lesions. The decline in endothelial FGF signaling input is due to the appearance of an FGF resistance state that is characterized by inflammation-dependent reduction in expression and activation of key components of the FGF signaling cascade. These results establish FGF signaling as a critical factor in maintenance of endothelial homeostasis and point to an unexpected role of Endo-MT in vascular pathology.


Related Papers

No related papers found

Powered by citation graph analysis